Literature DB >> 11997403

Is surgery still the preferred option for coronary revascularisation in diabetics with multivessel coronary disease?

A Kapur, I S Malik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11997403      PMCID： PMC1767088          DOI： 10.1136/heart.87.5.407

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  29 in total

1.  Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2000-12-16       Impact factor: 79.321

Review 2.  Coronary in-stent restenosis: current status and future strategies.

Authors:  Harry C Lowe; Stephen N Oesterle; Levon M Khachigian
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

3.  Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery.

Authors:  D L Bhatt; D P Chew; A T Hirsch; P A Ringleb; W Hacke; E J Topol
Journal:  Circulation       Date:  2001-01-23       Impact factor: 29.690

4.  Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators.

Authors:  A Rodriguez; V Bernardi; J Navia; J Baldi; L Grinfeld; J Martinez; D Vogel; R Grinfeld; A Delacasa; M Garrido; R Oliveri; E Mele; I Palacios; W O'Neill
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

5.  Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

Authors:  D L Bhatt; S P Marso; A M Lincoff; K E Wolski; S G Ellis; E J Topol
Journal:  J Am Coll Cardiol       Date:  2000-03-15       Impact factor: 24.094

6.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.

Authors:  P W Serruys; F Unger; J E Sousa; A Jatene; H J Bonnier; J P Schönberger; N Buller; R Bonser; M J van den Brand; L A van Herwerden; M A Morel; B A van Hout
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

Review 7.  Current perspectives on interventional treatment strategies in diabetic patients with coronary artery disease.

Authors:  R Kornowski; A J Lansky
Journal:  Catheter Cardiovasc Interv       Date:  2000-06       Impact factor: 2.692

8.  Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status.

Authors: 
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

9.  Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST)

Authors:  S B King; A S Kosinski; R A Guyton; N J Lembo; W S Weintraub
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

10.  Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.

Authors:  S P Marso; A M Lincoff; S G Ellis; D L Bhatt; J F Tanguay; N S Kleiman; T Hammoud; J E Booth; S K Sapp; E J Topol
Journal:  Circulation       Date:  1999 Dec 21-28       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.